Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pfaar

Showing results (81-90 of 308) with videos related to

Pageof 31
Sort By:
Drugs in Context|July 31, 2023
The treatment of mild upper respiratory tract infections - a position paper with recommendations for best practiceAndrew Smith, Peter Kardos, Oliver Pfaar, et al.
Allergologie Select|December 6, 2021
Nonpharmacological measures to prevent allergic symptoms in pollen allergy: A critical reviewKarl-Christian Bergmann, Markus Berger, Ludger Klimek, et al.
Allergy|June 24, 2020
The development of birch pollen seasons over 30 years in Munich, Germany-An EAACI Task Force reportKarl-Christian Bergmann, Jeroen Buters, Kostas Karatzas, et al.
International Archives of Allergy and Immunology|November 28, 2012
Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparationOliver Pfaar, Esther van Twuijver, Heike Hecker, et al.
Clinical and Translational Allergy|January 11, 2025
Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approachOliver Pfaar, Anju T Peters, Camille Taillé, et al.
Allergologie Select|March 29, 2024
Eosinophil granulocytes in chronic inflammatory respiratory diseases and CRSwNP: Function, immunological basis, and clinical significanceFelix Klimek, Christoph Bergmann, Jan Hagemann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 1, 2026
The management of NSAID-ERD patients in the current treatment landscape: aspirin desensitization, biologics, both, or neither?Whitney W Stevens, Irina Bobolea, Joaquim Mullol, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical ImmunologyOliver Pfaar, Eckard Hamelmann, Ludger Klimek, et al.
Allergologie Select|March 1, 2021
Anti-IgE: A treatment option in allergic rhinitis?Oliver Pfaar, Francesca Gehrt, Hansen Li, et al.
Allergy|October 13, 2022
Patient-reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real lifeFarah Bahbah, Catherine Gentil, Bernardo Sousa-Pinto, et al.
Pageof 31

Showing results (81-90 of 308) with videos related to

Sort By:
Pageof 31
Drugs in Context|July 31, 2023
The treatment of mild upper respiratory tract infections - a position paper with recommendations for best practiceAndrew Smith, Peter Kardos, Oliver Pfaar, et al.
Allergologie Select|December 6, 2021
Nonpharmacological measures to prevent allergic symptoms in pollen allergy: A critical reviewKarl-Christian Bergmann, Markus Berger, Ludger Klimek, et al.
Allergy|June 24, 2020
The development of birch pollen seasons over 30 years in Munich, Germany-An EAACI Task Force reportKarl-Christian Bergmann, Jeroen Buters, Kostas Karatzas, et al.
International Archives of Allergy and Immunology|November 28, 2012
Accelerated up-dosing of subcutaneous immunotherapy with a registered allergoid grass pollen preparationOliver Pfaar, Esther van Twuijver, Heike Hecker, et al.
Clinical and Translational Allergy|January 11, 2025
Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approachOliver Pfaar, Anju T Peters, Camille Taillé, et al.
Allergologie Select|March 29, 2024
Eosinophil granulocytes in chronic inflammatory respiratory diseases and CRSwNP: Function, immunological basis, and clinical significanceFelix Klimek, Christoph Bergmann, Jan Hagemann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 1, 2026
The management of NSAID-ERD patients in the current treatment landscape: aspirin desensitization, biologics, both, or neither?Whitney W Stevens, Irina Bobolea, Joaquim Mullol, et al.
Clinical and Translational Allergy|March 28, 2022
Allergen immunotherapy during the COVID-19 pandemic-A survey of the German Society for Allergy and Clinical ImmunologyOliver Pfaar, Eckard Hamelmann, Ludger Klimek, et al.
Allergologie Select|March 1, 2021
Anti-IgE: A treatment option in allergic rhinitis?Oliver Pfaar, Francesca Gehrt, Hansen Li, et al.
Allergy|October 13, 2022
Patient-reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real lifeFarah Bahbah, Catherine Gentil, Bernardo Sousa-Pinto, et al.
Pageof 31